Core Viewpoint - 联易融科技-W (09959) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will spend HKD 7.378 million to repurchase 2.4 million shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 聯易融科技集團（於開曼群島註冊成立以不同投票權控制的有限公司) 呈交日期： 2025年10月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 不同投票權架構公司普通股 | 股份類別 B | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | | 09959 | 說明 普通股 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | ...

Major Events - Minglue Technology (02718) plans to offer 7.219 million Class A shares globally from October 23 to October 28, with cornerstone subscriptions amounting to $59 million [1] - Wisco Properties (00230) received a privatization offer from Wisco Hong Kong at a premium of approximately 104.08%, with trading resuming on October 24 [1] - Junyu Foundation (01757) was acquired by China Venture Capital Holdings for 75% of its shares at a discount of about 79.06%, with trading resuming on October 24 [1] - Kangda Foods (00834) was acquired by Gaosi Shi for approximately 54.69% of the company’s shares at a premium of about 16.23%, with trading resuming on October 24 [1] - Hutchison China MediTech (00013) presented data on HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targeted and Cancer Therapeutics [1] - Giant Bio (02367) received a medical device registration certificate for its Type I α1 collagen lyophilized fiber product [1] - Yiming Anke-B (01541) completed the first patient dosing in the Phase IB/II clinical trial of IMM2510 combined with IMM01 [1] - Heng Rui Medicine (01276) received approval to conduct clinical trials for injection of Rikan Trastuzumab [1] - Hansoh Pharmaceutical (03692) had its application for HS-10365 capsule marketing approval accepted by the National Medical Products Administration [1] - Baixin An-B (02185) completed market access and the first commercial surgery for the IBERIS® RDN system in Switzerland [1] - Haotian International Construction Investment (01341) purchased a total of 646 units of Ethereum as of October 23 [1] Share Buybacks/Reductions - Cornerstone Pharmaceuticals-B (02616) saw CEO Yang Jianxin and senior management purchase an additional 1 million shares [2] - Midea Group (00300) repurchased 1.3434 million A shares for approximately 99.998 million yuan on October 23 [2] - China Communications Construction (01800) repurchased 119.45 million A shares for approximately 10.5994 million yuan on October 23 [2] - Mengniu Dairy (02319) repurchased 700,000 shares for approximately 10.0692 million HKD on October 23 [2] - Lianlian Digital (02598) spent about 7.5555 million HKD to repurchase 967,000 shares on October 23 [2] - Lianyi Rong Technology-W (09959) repurchased 2.47 million shares for approximately 7.4137 million HKD on October 23 [2] - Heng Rui Medicine (01276) repurchased 97,500 A shares for approximately 6.2808 million yuan on October 23 [2] - Gushengtang (02273) repurchased 19,860 shares for approximately 5.8634 million HKD on October 23 [2] Operating Performance - Ping An Good Doctor (01833) reported total revenue of approximately 3.725 billion yuan for the first three quarters, a year-on-year increase of 13.6%, and plans to continue expanding AI technology to enhance medical service efficiency and quality [2] - Sands China Ltd. (01928) reported a 7.5% year-on-year increase in net revenue to $1.9 billion for the third quarter [2] - Livzon Pharmaceutical (01513) announced a net profit attributable to shareholders of 1.754 billion yuan for the first three quarters, a year-on-year increase of 4.86% [2] - China Railway Construction (01186) signed new contracts totaling 1.518765 trillion yuan in the first three quarters, a year-on-year increase of 3.08% [2] - Prada (01913) reported net revenue of 4.07 billion euros for the first three quarters, a year-on-year increase of 9% [2] Additional Performance Metrics - Baio Family Interactive (02100) reported 10.2 million active accounts in the third quarter, a year-on-year increase of 37.8% [3] - Anton Oilfield Services (03337) secured new orders worth 1.273 billion yuan in the third quarter [3]

Core Viewpoint - The company, Lianyi Rong Technology-W, has been actively repurchasing its shares, indicating a strategy to support its stock price amidst a decline in market performance [2][3]. Share Buyback Summary - On October 23, the company repurchased 2.47 million shares at a price range of HKD 2.930 to HKD 3.080, totaling HKD 7.41 million [2]. - The stock closed at HKD 3.030 on the same day, reflecting a decrease of 1.94%, with a total trading volume of HKD 26.96 million [2]. - Since September 11, the company has conducted share buybacks for 29 consecutive days, acquiring a total of 61.95 million shares for a cumulative amount of HKD 202 million, during which the stock price has dropped by 5.02% [2][3]. Year-to-Date Buyback Activity - Year-to-date, the company has executed 37 buyback transactions, acquiring a total of 73.77 million shares for a total expenditure of HKD 232 million [3]. - Detailed buyback data shows fluctuations in the number of shares repurchased and the prices, with the highest buyback price recorded at HKD 3.610 and the lowest at HKD 1.050 [4].

联易融科技-W(09959)发布公告，于2025年10月23日，该公司斥资741.37万港元回购247万股。 ...

智通财经APP讯，联易融科技-W(09959)发布公告，于2025年10月23日，该公司斥资741.37万港元回购 247万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 聯易融科技集團（於開曼群島註冊成立以不同投票權控制的有限公司) 呈交日期： 2025年10月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 不同投票權架構公司普通股 | 股份類別 B | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | | 09959 | 說明 | 普通股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | ...

Core Viewpoint - On October 22, 35 Hong Kong-listed companies conducted share buybacks, totaling 10.4965 million shares and an amount of 52.7745 million HKD [1][2]. Group 1: Buyback Details - The company with the highest buyback amount on October 22 was AAC Technologies, with a buyback amount of 11.9098 million HKD for 300,000 shares [1][2]. - Linklogis Technology-W followed with a buyback of 2.430 million shares, amounting to 7.4708 million HKD [1][2]. - Mengniu Dairy repurchased 500,000 shares for 7.1714 million HKD [1][2]. Group 2: Year-to-Date Buyback Totals - AAC Technologies has conducted multiple buybacks this year, with a cumulative buyback amount of 858.628 million HKD [2]. - Linklogis Technology-W's total buyback amount for the year reached 225.0668 million HKD [2]. - Mengniu Dairy's year-to-date buyback amount stands at 45.832 million HKD [2]. Group 3: Buyback Volume Rankings - The highest number of shares repurchased on October 22 was by Linklogis Technology-W, with 2.43 million shares [1][2]. - Other notable buybacks in terms of volume included MorningX Technology with 1.064 million shares and China Hengyou Group with 1 million shares [1][2].

Summary of Key Points Core Viewpoint - A total of 30 companies, including major players like 瑞声科技 (AAC Technologies) and 蒙牛乳业 (Mengniu Dairy), conducted share buybacks on October 22, 2025, indicating a trend of companies returning capital to shareholders amidst market conditions. Group 1: Buyback Details - 瑞声科技 (AAC Technologies) had the largest buyback amount, repurchasing 300,000 shares for a total of 11.90 million yuan [1] - 联易融科技-W (Lianyi Technology) repurchased 2.43 million shares, totaling 7.47 million yuan, representing 3.288% of its total share capital [2] - 蒙牛乳业 (Mengniu Dairy) bought back 500,000 shares for 7.17 million yuan, which is 0.517% of its total share capital [2] Group 2: Other Notable Buybacks - 康臣药业 (Kangchen Pharmaceutical) repurchased 283,000 shares for 4.33 million yuan, accounting for 7.969% of its total share capital [2] - 连连数字 (Lianlian Digital) bought back 440,000 shares for 3.54 million yuan, which is 0.138% of its total share capital [2] - 固生堂 (Gushengtang) repurchased 91,300 shares for 2.75 million yuan, representing 2.076% of its total share capital [2] Group 3: Additional Companies Involved - 绿城服务 (Greentown Service) repurchased 216,000 shares for 989,300 yuan, which is 0.007% of its total share capital [2] - 歌礼制药-B (Galactico Pharmaceutical) bought back 100,000 shares for 926,500 yuan, accounting for 0.068% of its total share capital [2] - 医渡科技 (Yidu Technology) repurchased 17,700 shares for 99,800 yuan, representing 0.330% of its total share capital [2]

Summary of the Conference Call for 联易融科技 Company Overview - **Company**: 联易融科技 (Lianyi Rong Technology) - **Industry**: Supply Chain Financial Technology Solutions Key Points and Arguments 1. **Business Growth**: In Q3 2025, the multi-level circulation cloud business grew by 71% year-on-year, contributing to a 60% increase in the first nine months. The company expects this segment to grow by no less than 50% for the full year [2][3][4] 2. **Client Acquisition**: The company added over 380 core enterprise clients in the first nine months, with more than 90% coming from multi-level circulation clients. This influx has improved the penetration rate among existing clients [2][3][4] 3. **AMS and ABS Cloud Performance**: AMS and ABS cloud services saw over 20% quarter-on-quarter growth in Q3, with ABS cloud achieving a 26% year-on-year increase and over 150% quarter-on-quarter growth, indicating a rapid recovery in high-fee asset securitization [2][3][4] 4. **Web 3.0 Project**: The successful bid for China Mobile's Web 3 supply chain financial platform project marks significant progress in Web 3.0 innovation and lays the groundwork for future overseas multi-currency supply chain financial solutions [2][5][19] 5. **Revenue Drivers**: Future revenue growth is expected to come from an increase in multi-level circulation clients, higher penetration rates, a greater share of high-fee asset securitization products, successful Web 3 projects, and a continuous share buyback plan [2][7][21] 6. **AI Product Development**: The company’s AI products focus on financial institution cloud services, with expected revenue of 30-40 million RMB for the year, driven by efficient legal document verification and financing rule matching [4][23] 7. **Financial Performance Outlook**: The company anticipates flat or slightly declining revenue for 2025, with a goal of achieving breakeven in the second half of the year. Net profit targets are set at no less than 100 million RMB for 2026 and 200 million RMB for 2027 [4][21] 8. **Shareholder Returns**: The company has committed over 800 million RMB from IPO funds for buybacks and dividends, with a buyback plan of 8 billion USD currently in progress [22] Additional Important Information 1. **Client Retention**: The customer retention rate remained at 99% in Q3, indicating strong client loyalty [3] 2. **Cross-Border Cloud Platform**: The cross-border cloud platform utilizes blockchain technology to provide trade financing solutions, addressing high costs and long cycles associated with traditional methods [15][16] 3. **International Business Expansion**: The company is in the early stages of expanding its international business, focusing on Web 3 and stablecoin projects, with expectations for significant growth in the next 3-5 years [13][18] 4. **Future Plans**: The company plans to integrate supply chain finance into future stablecoin issuance frameworks, with project launches expected in 2026 [20] This summary encapsulates the key insights from the conference call, highlighting the company's growth trajectory, strategic initiatives, and future outlook in the supply chain financial technology sector.